000 01557 a2200433 4500
005 20250516160839.0
264 0 _c20140522
008 201405s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.1070
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYi, Yong Weon
245 0 0 _aTargeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells.
_h[electronic resource]
260 _bOncotarget
_cJul 2013
300 _a984-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aApoptosis
_xphysiology
650 0 4 _aBoronic Acids
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aChalcones
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aRNA, Small Interfering
_xgenetics
650 0 4 _aSirtuin 1
_xgenetics
650 0 4 _aTransfection
650 0 4 _aTriple Negative Breast Neoplasms
_xdrug therapy
650 0 4 _aTumor Suppressor Protein p53
_xgenetics
700 1 _aKang, Hyo Jin
700 1 _aKim, Hee Jeong
700 1 _aKong, Yali
700 1 _aBrown, Milton L
700 1 _aBae, Insoo
773 0 _tOncotarget
_gvol. 4
_gno. 7
_gp. 984-94
856 4 0 _uhttps://doi.org/10.18632/oncotarget.1070
_zAvailable from publisher's website
999 _c22910539
_d22910539